New York State Common Retirement Fund’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$607K Buy
11,000
+2,000
+22% +$69.9K ﹤0.01% 1928
2026
Q1
$269K Buy
9,000
+4,700
+109% +$160K ﹤0.01% 2122
2025
Q4
$136K Hold
4,300
– – ﹤0.01% 2467
2025
Q3
$75.3K Hold
4,300
– – ﹤0.01% 2790
2025
Q2
$49.1K Hold
4,300
– – ﹤0.01% 2947
2025
Q1
$31.7K Buy
+4,300
New +$45.5K ﹤0.01% 2899

Other funds holding MBX

New York State Common Retirement Fund's MBX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its MBX Biosciences (MBX) stake by 22% in Q2 2026, buying an estimated $69.9K and bringing the position to 11,000 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

New York State Common Retirement Fund first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • New York State Common Retirement Fund held 11,000 shares of MBX Biosciences worth $607K as of Q2 2026.
  • New York State Common Retirement Fund bought 2,000 MBX Biosciences shares in Q2 2026, an estimated $69.9K.
  • MBX Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1928 holding.
  • New York State Common Retirement Fund first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.